The treatment, which involves drawing blood and injecting it back several days later with new anti-inflammatory proteins that stimulate cell growth, is designed to treat inflammation as both a cause and symptom of tissue damage in the joints or lower back.
The therapy typically lasts five days, beginning with an evaluation and drawing of blood.
Related Articles on Pain Management:
myoscience Receives FDA Clearance for Pain Management Device
Pain Management Specialist Dr. John Keel Joins New England Baptist Hospital
Opposition Threatens Kentucky Drug Abuse Bill
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.